The U.S. Food and Drug Administration today approved the Maestro Rechargeable System for certain obese adults, the first weight loss treatment device that targets the nerve pathway between the brain and the stomach that controls feelings of hunger and fullness.
Colds can come from cold noses, according to a high-profile study in Proceedings of the National Academy of Sciences (PNAS).
Every summer, the news reports on a bacterium called Vibrio vulnificus found in warm saltwater that causes people to get sick, or die, after they eat raw tainted shellfish or when an open wound comes in contact with seawater.
Early detection of autism in children is the key for treatments to be most effective and produce the best outcomes.
Fibrosis is a constant feature of all chronic liver diseases.
The new regulations surpass standards required by U.S. Environmental Protection Agency.
The lab-grown tissue should soon allow researchers to test new drugs and study diseases in functioning human muscle outside of the human body.
These companies have an interesting year ahead of them.
Biologists found indications of a greater risk of parasitic infection due to climate change in ancient mollusk fossils.
Researchers have found a possible predictor for little understood -- but often disabling or even fatal -- stroke complications.
Most insects are covered with a thin layer of hydrocarbon molecules as a waterproofing barrier.
A new device offers a much more detailed picture of cellular communication.
Scientists have revealed that sugars on a specific mucus protein can induce eosinophil death and help combat asthma.
When 2 milliliters of blood are run through the chip, the tumor cells stick to the nanowires like Velcro.
Diabetes treatments have saved many lives, but in older patients with multiple medical conditions, aggressively controlling blood sugar with insulin and sulfonylurea drugs, could lead to over-treatment and hypoglycemia (low blood sugar), according to new research by Yale School of Medicine researchers.
In the coming year, while consumers will be treated to a dizzying array of augmented reality, wearables, and low-cost 3-D printers, computer researchers will be tackling the underlying technology issues that make such cutting-edge consumer electronics products possible.
In the race to find a safe and effective weight loss drug, much attention has focused on the chemical processes that store and use energy.
The fingers of papillary tumors often grow back after surgery, but flat carcinoma in situ cancers are typically more aggressive and more likely to spread.
In the midst of a worrisome flu season, health officials are pushing doctors to prescribe antiviral medicines more often.
The agreement will integrate genomics research conducted at Columbia with Biogen Idec’s understanding of disease mechanisms and pathways, and expertise in discovering new medicines.
Among the thorniest challenges in the study of speech perception, the invariance problem was first identified in the 1950s, when scientists began using instruments to analyze spoken language.
EPFL scientists have managed to get rats walking on their own again using a combination of electrical and chemical stimulation. But applying this method to humans would require multifunctional implants that could be installed for long periods of time on the spinal cord without causing any tissue damage.
MIT senior Katie Bodner thrives in fields that are full of unanswered questions: She arrived at the Institute with little research experience, and from a family with no scientists, but now a biological engineering major, she has found her place working on projects in synthetic biology, biological-based pharmaceuticals, and programmable vaccines.
New Year’s weight loss resolutions are in full swing, but despite all the hype about the latest wearable tracking devices, there’s little evidence that this technology alone can change behavior and improve health for those that need it most, according to a new online-first viewpoint piece in JAMA.
23andMe and Genentech team up to generate whole genome sequencing data for approximately 3,000 people in 23andMe's Parkinson's disease community.